Literature DB >> 26086596

Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials.

Klaus Gottlieb1, Simon Travis, Brian Feagan, Fez Hussain, William J Sandborn, Paul Rutgeerts.   

Abstract

BACKGROUND: Central reading of endoscopy (CROE) is crucial in determining who qualifies for a trial but also has a role, independent of the selected scoring system, in decreasing measurement noise that can obscure separation between placebo and active drug. Benefits of CROE may not be independent of the method chosen, and controversy exists about the ideal approach.
METHODS: Literature review and concept development.
RESULTS: Components to be considered in the reading algorithm are blinding, number of central readers, independent voting versus consensus panel, video recordings versus still images, and involvement of the site reader. Key concepts considered are endpoints, bias, power, and sample size derived from the Food and Drug Administration and European Medicines Agency guidelines, as well as the technological requirements and recruitment, qualification, and revalidation of central readers as applied to CROE.
CONCLUSIONS: Recording and CROE should be standardized, and an imaging charter developed with research on the different components and its overall impact.

Mesh:

Year:  2015        PMID: 26086596     DOI: 10.1097/MIB.0000000000000470

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  7 in total

1.  Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease.

Authors:  Reena Khanna; GuangYong Zou; Larry Stitt; Brian G Feagan; William J Sandborn; Paul Rutgeerts; John W D McDonald; Elena Dubcenco; Ronald Fogel; Remo Panaccione; Vipul Jairath; Sigrid Nelson; Lisa M Shackelton; Bidan Huang; Qian Zhou; Anne M Robinson; Barrett G Levesque; Geert D'Haens
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

2.  Machine Learning-based Prediction Models for Diagnosis and Prognosis in Inflammatory Bowel Diseases: A Systematic Review.

Authors:  Nghia H Nguyen; Dominic Picetti; Parambir S Dulai; Vipul Jairath; William J Sandborn; Lucila Ohno-Machado; Peter L Chen; Siddharth Singh
Journal:  J Crohns Colitis       Date:  2022-03-14       Impact factor: 10.020

Review 3.  Placebo Rates in Randomized Controlled Trials of Pouchitis Therapy.

Authors:  Jonathan Athayde; Sarah C Davies; Claire E Parker; Leonardo Guizzetti; Christopher Ma; Reena Khanna; Brian G Feagan; Vipul Jairath
Journal:  Dig Dis Sci       Date:  2018-07-11       Impact factor: 3.199

4.  Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.

Authors:  Adérson Omar Mourão Cintra Damião; Matheus Freitas Cardoso de Azevedo; Alexandre de Sousa Carlos; Marcela Yumi Wada; Taciana Valéria Marcolino Silva; Flávio de Castro Feitosa
Journal:  World J Gastroenterol       Date:  2019-03-07       Impact factor: 5.742

5.  Performance of a Deep Learning Model vs Human Reviewers in Grading Endoscopic Disease Severity of Patients With Ulcerative Colitis.

Authors:  Ryan W Stidham; Wenshuo Liu; Shrinivas Bishu; Michael D Rice; Peter D R Higgins; Ji Zhu; Brahmajee K Nallamothu; Akbar K Waljee
Journal:  JAMA Netw Open       Date:  2019-05-03

6.  The Impact of Raising the Bar for Clinical Trials in Ulcerative Colitis.

Authors:  Bruce E Sands; Adam S Cheifetz; Chudy I Nduaka; Daniel Quirk; Wenjin Wang; Eric Maller; Gary S Friedman; Chinyu Su; Peter D R Higgins
Journal:  J Crohns Colitis       Date:  2019-09-19       Impact factor: 9.071

Review 7.  Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments.

Authors:  Klaus Gottlieb; Marco Daperno; Keith Usiskin; Bruce E Sands; Harris Ahmad; Colin W Howden; William Karnes; Young S Oh; Irene Modesto; Colleen Marano; Ryan William Stidham; Walter Reinisch
Journal:  Gut       Date:  2020-07-22       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.